A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer.

Trial Profile

A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2011

At a glance

  • Drugs Anastrozole; Letrozole
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms ARI-NIS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 23 Dec 2009 Planned end date changed from 1 Feb 2011 to 1 Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top